MoneyWorks4Me

Syncom Formulations India informs about updates

03 Jan 2026 Evaluate
Syncom Formulations India has informed that it enclosed announcement in continuation of SYNCOM/SE/2025-26 dated 5th April, 2025 pursuant to Regulation 30 read with Schedule III Part A of SEBI (LODR) Regulations, 2015 for the demand raised under section 74(5) of CGST Act, 2017 for Ineligible Input Tax Credits also section 122 of CGST Act, 2017 for penalty.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..